Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole prophylaxis during antithymocyte globulin treatment for hypoplastic myelodysplastic syndrome/aplastic anemia
KCT0003679Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of posaconazole in aplastic anemia, myelodysplastic syndrome (MDS), sponsored by Seoul National University Hospital. Started Aug 2018; status: completed.
02
Drugs
posaconazole
03
Conditions
aplastic anemiamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on KCT0003679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003679.